Skip to main navigation
Cue Logo
Skip to Content
Cue Logo
  • Overview
  • News & Events
    • News Releases
    • Events and Presentations
  • Corporate Governance
    • Governance Overview
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact Investor Relations

News
Releases

Date Title
Jun 06, 2023
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
May 31, 2023
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
May 10, 2023
Cue Health Reports First Quarter 2023 Financial Results
May 09, 2023
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
May 08, 2023
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home
Apr 26, 2023
Cue Health to Announce First Quarter 2023 Financial Results
Mar 20, 2023
Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test
Mar 15, 2023
Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results
Mar 13, 2023
Cue Health’s New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
Mar 02, 2023
Cue Health Collaborates with Pfizer to Provide People who Test Positive for COVID-19 with Actionable Health Information to Better Inform their Treatment Journey

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 12

Shareholder Tools

Print Page Print Page
Email Alerts Email Alerts
RSS RSS
Contact Contact

This website contains depictions of contemplated future products and future care offerings that are still under development by Cue Health and that have not received regulatory authorization, clearance or approval. Currently, the only products authorized for commercial sale in the United States are Cue Health’s COVID-19 tests, which are currently commercially available in the United States pursuant to two Emergency Use Authorizations from the U.S. Food & Drug Administration.

  • © 2023 Cue Health Inc. All rights reserved. Cue and the Cue logo are registered trademarks of Cue Health Inc.